InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: Emergcy post# 33690

Wednesday, 01/16/2019 3:37:59 PM

Wednesday, January 16, 2019 3:37:59 PM

Post# of 232913
Financing issues have little to do with Nader and mostly to do with what the debt / equity market will offer to a BioTech with zero revenue. CYDY's management team executes at the direction of the BOD. While I do not like the dilution, it is a necessary "evil". Let's not blame the messenger (Management). As long as we get to the "finish line", whether BO or JV or Licensing, etc. I'm good with it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News